Association of MTHFRC677T gene polymorphism with metabolic syndrome in a Chinese population: a case–control study

Objective To investigate the association of the MTHFRC677T gene polymorphism with metabolic syndrome (MetS) in people in Hubei Province, China.Methods A case–control study was conducted with 651 subjects with MetS (MetS group) and 727 healthy controls (control group) at Renmin Hospital of Wuhan University between January and December 2016. The MTHFRC677T genotype was detected by the gene chip technique and clinical data were collected.Results Body mass index, waist circumference, the waist-hip-ratio, systolic and diastolic blood pressure, fasting blood glucose, fasting insulin, triglyceride, total cholesterol, low-density lipoprotein-cholesterol, and homocysteine levels, and the homeostasis model assessment of insulin resistance were higher in the MetS group than in controls. The risk of MetS was higher for the TT genotype and T allele carriers than for the CC genotype and C allele carriers. With MetS, the TT genotype increased the risk of elevated blood pressure, fasting glucose levels, and triglyceride levels. Patients with MetS and the TT genotype showed more severe abdominal obesity, dyslipidaemia, insulin resistance, elevated blood pressure, elevated fasting glucose levels, and hyperhomocysteinaemia compared with those with the CC genotype.Conclusions In this population, MTHFRC677T gene polymorphism may be a risk factor for MetS.